Currently, 13 CAR-T treatments have been approved for regulatory approval.
Currently, 13 CAR-T treatments have been approved for regulatory approval.
Date:
About
FigureAsia (ISSN: 3005-3978) is a premier international magazine dedicated to in-depth coverage of Asia. It offers authoritative analysis and reportage across critical domains, including politics, economics, society, culture, and technology. FigureAsia serves as a distinguished platform, delivering nuanced insights and comprehensive perspectives to an informed Asian readership, with a focus on both regional dynamics and global trends.
Magazine
News
Baidu debuts cost-effective Ernie AI model
The Ernie 4.5 Turbo offers faster response times and...
Beasts consider Brazil's main data investments: Source
Bytedance reportedly held talks with Casa Dos Ventos to...
Microsoft relies more on third-party companies for sales in the AI era
A Microsoft spokesman said the adjustments were designed to...
Subscribe
© 2024 FigureAsia Publishing Group Limited All Rights Reserved.
Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information | Ad Choices
FigureAsia may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.
ISSN: 3005-3978 is the property of FigureAsia. and its licensors. All rights reserved. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.